Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of Ferroptosis and Emerging Links to the Pathology of Neurodegenerative Diseases
Yiyan Sun, Xiaohuan Xia, Diksha Basnet, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Pharmacological Inhibition of Ferroptosis as a Therapeutic Target for Neurodegenerative Diseases and Strokes
Yumin Wang, Shuang Wu, Qiang Li, et al.
Advanced Science (2023) Vol. 10, Iss. 24
Open Access | Times Cited: 71
Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases
Yumin Wang, Jing Hu, Shuang Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 64
Pharmacological inhibition of ferroptosis as a therapeutic target for sepsis-associated organ damage
Liang Huo, Chunfeng Liu, Yujun Yuan, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115438-115438
Closed Access | Times Cited: 47
Research on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases
Yi Wang, Meng-nan Lv, Weijiang Zhao
Ageing Research Reviews (2023) Vol. 91, pp. 102035-102035
Open Access | Times Cited: 41
Medical gas plasma technology: Roadmap on cancer treatment and immunotherapy
Sander Bekeschus
Redox Biology (2023) Vol. 65, pp. 102798-102798
Open Access | Times Cited: 40
Ferroptosis Regulated by Hypoxia in Cells
Xiangnan Zheng, Yuqiong Liang, Cen Zhang
Cells (2023) Vol. 12, Iss. 7, pp. 1050-1050
Open Access | Times Cited: 29
Oxytosis/Ferroptosis in Neurodegeneration: the Underlying Role of Master Regulator Glutathione Peroxidase 4 (GPX4)
Nawab John Dar, Urmilla John, Nargis Bano, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 3, pp. 1507-1526
Closed Access | Times Cited: 23
The role of iron metabolism in the pathogenesis and treatment of multiple sclerosis
Eduardo Duarte-Silva, Sven G. Meuth, Christina Alves Peixoto
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
Driving factors of neuronal ferroptosis
Julie Jacquemyn, Isha Ralhan, Maria S. Ioannou
Trends in Cell Biology (2024) Vol. 34, Iss. 7, pp. 535-546
Closed Access | Times Cited: 12
Targeting novel regulated cell death：Ferroptosis, pyroptosis, and autophagy in sepsis-associated encephalopathy
Jingjing Sun, Joshua S. Fleishman, Xueyan Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116453-116453
Open Access | Times Cited: 11
Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance
Hongquan Wang, Joshua S. Fleishman, Sihang Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Ferroptosis: underlying mechanisms and involvement in neurodegenerative diseases
Yi Wang, HongJing Li, QianXiong He, et al.
APOPTOSIS (2023) Vol. 29, Iss. 1-2, pp. 3-21
Closed Access | Times Cited: 15
The molecular mechanism of ferroptosis and its relationship with Parkinson's disease
Yan Su, Yue Jiao, Sheng Cai, et al.
Brain Research Bulletin (2024) Vol. 213, pp. 110991-110991
Open Access | Times Cited: 6
Cerebral iron accumulation in multiple sclerosis: Pathophysiology and therapeutic implications
Geir Bjørklund, David R. Wallace, Tony Hangan, et al.
Autoimmunity Reviews (2025), pp. 103741-103741
Closed Access
Loureirin C inhibits ferroptosis and apoptosis in 6-OHDA-induced Parkinson's model
Zhongmei Chen, Ronghui Hou, Yuping Zhang, et al.
Tissue and Cell (2025) Vol. 93, pp. 102721-102721
Closed Access
Identifying potential genes driving ferroptosis in the substantia nigra and dopaminergic neurons in Parkinson's disease
Arunaloke Chakrabarti, Sonia Verma
Molecular and Cellular Neuroscience (2025) Vol. 132, pp. 103993-103993
Closed Access
Targeting Ferroptosis in Rare Neurological Disorders Including Pediatric Conditions: Innovations and Therapeutic Challenges
Ahmed D. Alatawi, Krishnaraju Venkatesan, Khalid A. Asseri, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 265-265
Open Access
Ferroptosis in thyroid cancer: mechanisms, current status, and treatment
Wenzhi Tian, Xi Su, Chenchen Hu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Mitochondrial dysfunction, iron accumulation, lipid peroxidation, and inflammasome activation in cellular models derived from patients with multiple sclerosis
Raquel García-Salas, Paula Cilleros-Holgado, A Spirito, et al.
Aging (2025)
Open Access
Multiomics identify the gene expression signature of the spinal cord during aging process
Lintao Xu, Jingyu Wang, Jinjie Zhong, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Capacity of fullerenols to modulate neurodegeneration induced by ferroptosis: focus on multiple sclerosis
Mariana Seke, Aleksandra Stanković, Maja Živković
Multiple Sclerosis and Related Disorders (2025), pp. 106378-106378
Closed Access
The Regulation of Ferroptosis by Noncoding RNAs
Xiangnan Zheng, Cen Zhang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13336-13336
Open Access | Times Cited: 14
Natural products for the treatment of neurodegenerative diseases
Donghan Cui, Yajuan Chen, Bengui Ye, et al.
Phytomedicine (2023) Vol. 121, pp. 155101-155101
Closed Access | Times Cited: 14
E3 ligases and DUBs target ferroptosis: A potential therapeutic strategy for neurodegenerative diseases
Linxia Lu, Cili Jifu, Jun Xia, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116753-116753
Open Access | Times Cited: 4
Inducing ferroptosis by traditional medicines: a novel approach to reverse chemoresistance in lung cancer
Yumin Wang, Jing Hu, Joshua S. Fleishman, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top